Annual Cash & Cash Equivalents
$401.80 K
-$2.76 M-87.31%
31 December 2023
Summary:
Qualigen Therapeutics annual cash & cash equivalents is currently $401.80 thousand, with the most recent change of -$2.76 million (-87.31%) on 31 December 2023. During the last 3 years, it has fallen by -$17.14 million (-97.71%). QLGN annual cash & cash equivalents is now -98.32% below its all-time high of $23.98 million, reached on 01 December 2020.QLGN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$388.20 K
+$269.50 K+227.04%
30 September 2024
Summary:
Qualigen Therapeutics quarterly cash and cash equivalents is currently $388.20 thousand, with the most recent change of +$269.50 thousand (+227.04%) on 30 September 2024. Over the past year, it has dropped by -$13.60 thousand (-3.38%). QLGN quarterly cash and cash equivalents is now -98.23% below its all-time high of $21.95 million, reached on 31 March 2021.QLGN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -3.4% |
| 3 y3 years | -97.7% | -97.8% |
| 5 y5 years | - | - |
QLGN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -97.7% | at low | -97.8% | +316.5% |
| 5 y | 5 years | -98.3% | +162.4% | -98.2% | +316.5% |
| alltime | all time | -98.3% | +162.4% | -98.2% | +316.5% |
Qualigen Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $388.20 K(+227.0%) |
| June 2024 | - | $118.70 K(+27.4%) |
| Mar 2024 | - | $93.20 K(-76.8%) |
| Dec 2023 | $401.80 K(-87.3%) | $401.80 K(-80.6%) |
| Sept 2023 | - | $2.07 M(+54.6%) |
| June 2023 | - | $1.34 M(-69.2%) |
| Mar 2023 | - | $4.36 M(+37.8%) |
| Dec 2022 | $3.17 M | $3.17 M(-52.2%) |
| Sept 2022 | - | $6.62 M(-32.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $9.75 M(-28.4%) |
| Mar 2022 | - | $13.61 M(-22.4%) |
| Dec 2021 | $17.54 M(-26.9%) | $17.54 M(+42.4%) |
| Sept 2021 | - | $12.32 M(-19.1%) |
| June 2021 | - | $15.23 M(-30.6%) |
| Mar 2021 | - | $21.95 M(+51.7%) |
| Dec 2020 | $23.98 M(>+9900.0%) | - |
| Sept 2020 | - | $14.47 M(+527.2%) |
| June 2020 | - | $2.31 M |
| Mar 2020 | $153.10 K | - |
FAQ
- What is Qualigen Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Qualigen Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of QLGN is $401.80 K
What is the all time high annual cash & cash equivalents for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual cash & cash equivalents is $23.98 M
What is Qualigen Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of QLGN is $388.20 K
What is the all time high quarterly cash and cash equivalents for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly cash and cash equivalents is $21.95 M
What is Qualigen Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, QLGN quarterly cash and cash equivalents has changed by -$13.60 K (-3.38%)